Screening for active tuberculosis: Methodological challenges in implementation and evaluation

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 7, 2013, Pages 856-865

  Golub, Jonathan E ^a   Dowdy, D W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diagnostic techniques and procedures; Epidemiology; Tuberculosis

Indexed keywords

ANTIBIOTIC RESISTANCE; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE PLANNING; HIGH RISK POPULATION; HUMAN; INCIDENCE; MORTALITY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RESOURCE ALLOCATION; REVIEW; RISK ASSESSMENT; SCREENING; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE; THORAX RADIOGRAPHY; TUBERCULOSIS; TUBERCULOSIS CONTROL;

HUMANS; MASS SCREENING; OUTCOME ASSESSMENT (HEALTH CARE); PROGRAM DEVELOPMENT; RISK FACTORS; TUBERCULOSIS; WORLD HEALTH;

EID: 84878910621     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.13.0059     Document Type: Review

References (83)

1. Raviglione M C, Pio A. Evolution of WHO policies for tuberculosis control, 1948-2001. Lancet 2002; 359: 775-780. (Pubitemid 34215081)
2. Raviglione M C, Uplekar M W. WHO's new Stop TB Strategy. Lancet 2006; 367: 952-955.
3. Glaziou P, Floyd K, Korenromp E L, et al. Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality. Bull World Health Organ 2011; 89: 573-582.
4. World Health Organization. Global tuberculosis report 2012. WHO/HTM/TB/2012.6. Geneva, Switzerland: WHO, 2012.
5. Dowdy D W, Chaisson R E. The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection. Bull World Health Organ 2009; 87: 296-304.
6. Lönnroth K, Corbett E, Golub J, et al. Systematic screening for active tuberculosis: rationale, definitions and key considerations. Int J Tuberc Lung Dis 2013; 17: 289-298.
7. Kranzer K, Afnan-Holmes H, Tomlin K, et al. The benefits to communities and individuals of screening for active tuberculosis disease: a systematic review. Int J Tuberc Lung Dis 2013; 17: 432-446.
8. Lönnroth K, Castro K G, Chakaya J M, et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 2010; 375: 1814-1829.
9. Fraser C, Riley S, Anderson R M, Ferguson N M. Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci USA 2004; 101: 6146-6151. (Pubitemid 38520542)
10. Ayles H M, Sismanidis C, Beyers N, Hayes R J, Godfrey-Faussett P. ZAMSTAR, the Zambia South Africa TB and HIV Reduction Study: design of a 2x2 factorial community randomized trial. Trials 2008; 9(1): 63.
11. Ayles H, The ZAMSTAR Study Team. The ZAMSTAR study - community and household interventions to reduce tuberculosis in Zambian and South African communities. 42nd Union World Conference on Lung Health, Lille, France, 26-30 October 2011. Int J Tuberc Lung Dis 2011; 15(Suppl 3): S45. [Abstract]
12. Corbett E L, Bandason T, Duong T, et al. Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial. Lancet 2010; 376: 1244-1253.
13. Schuurman E M W, Srisaenpang S, Pinitsoontorn S, Bijleveld I, Vaeteewoothacharn K, Methapat C. The rapid village survey in tuberculosis control. Tubercle Lung Dis 1996; 77: 549-554. (Pubitemid 27023154)
14. Corbett E L, Charalambous S, Moloi V M, et al. Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. Am J Respir Crit Care Med 2004; 170: 673-679. (Pubitemid 39202210)
15. Cegielski J P, McMurray D N. The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals. Int J Tuberc Lung Dis 2004; 8: 286-298. (Pubitemid 38624865)
16. Corbett E L, Churchyard G J, Clayton T C, et al. HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners. AIDS 2000; 14: 2759-2768. (Pubitemid 32118730)
17. Dooley K E, Chaisson R E. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009; 9: 737-746.
18. Lin H, Ezzati M, Murray M. Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med 2007; 4: e142.
19. Bam T S, Enarson D A, Hinderaker S G, Bam D S. Longer delay in accessing treatment among current smokers with new sputum smear-positive tuberculosis in Nepal. Int J Tuberc Lung Dis 2012; 16: 822-827.
20. Chung K F, Pavord I D. Prevalence, pathogenesis, and causes of chronic cough. Lancet 2008; 371: 1364-1374. (Pubitemid 351540823)
21. Boehme C C, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363: 1005-1015.
22. Vassall A, van Kampen S, Sohn H, et al. Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis. PLoS Med 2011; 8: e1001120.
23. Dorman S E, Chihota V N, Lewis J J, et al. Performance characteristics of the Cepheid Xpert MTB/RIF test in a tuberculosis prevalence survey. PLoS ONE 2012; 7: e43307.
24. Boehme C C, Nicol M P, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011; 377: 1495-1505.
25. Glaziou P, van der Werf M J, Onozaki I, Dye C. Tuberculosis prevalence surveys: rationale and cost. Int J Tuberc Lung Dis 2008; 12: 1003-1008.
26. Ayles H, Schaap A, Nota A, et al. Prevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities: implications for tuberculosis control in the era of HIV. PLoS ONE 2009; 4: e5602.
27. Wood R, Middelkoop K, Myer L, et al. Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am J Respir Crit Care Med 2007; 175: 87-93. (Pubitemid 46105314)
28. Corbett E L, Bandason T, Cheung Y B, et al. Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease. PLoS Med 2007; 4: e22.
29. Hoa N B, Cobelens F G J, Sy D N, Nhung N V, Borgdorff M W, Tiemersma E W. Yield of interview screening and chest X-ray abnormalities in a tuberculosis prevalence survey. Int J Tuberc Lung Dis 2012; 16: 762-767.
30. den Boon S, White N W, van Lill S W P, et al. An evaluation of symptom and chest radiographic screening in tuberculosis prevalence surveys. Int J Tuberc Lung Dis 2006; 10: 876-882. (Pubitemid 44197848)
31. Hoa N B, Sy D N, Nhung N V, Tiemersma E W, Borgdorff M W, Cobelens F G. National survey of tuberculosis prevalence in Vietnam. Bull World Health Organ 2010; 88: 273-280.
32. Behr M A, Warren S A, Salamon H, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999; 353: 444-449. (Pubitemid 29067335)
33. Lawn S D, Kerkhoff A D, Wood R. Progression of subclinical culture-positive tuberculosis to symptomatic disease in HIV-infected individuals. AIDS 2011; 25: 2190-2191.
34. van't Hoog A H, Meme H K, Laserson K F, et al. Screening strategies for tuberculosis prevalence surveys: the value of chest radiography and symptoms. PLoS ONE 2012; 7: e38691.
35. Story A, Aldridge R W, Abubakar I, et al. Active case finding for pulmonary tuberculosis using mobile digital chest radiography: an observational study. Int J Tuberc Lung Dis 2012; 16: 1461-1467.
36. Djoba Siawaya J F, Bapela N B, Ronacher K, et al. Immune parameters as markers of tuberculosis extent of disease and early prediction of anti-tuberculosis chemotherapy response. J Infect 2008; 56: 340-347.
37. Dowdy D W, Golub J E, Chaisson R E, Saraceni V. Heterogeneity in tuberculosis transmission and the role of geographic hotspots in propagating epidemics. Proc Natl Acad Sci USA 2012; 109: 9557-9562.
38. Shapiro A E, Variava E, Rakgokong M H, et al. Community-based targeted case finding for tuberculosis and HIV in household contacts of patients with tuberculosis in South Africa. Am J Respir Crit Care Med 2012; 185: 1110-1116.
39. Basu S, Andrews J R, Poolman E M, et al. Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study. Lancet 2007; 370: 1500-1507. (Pubitemid 47628865)
40. Winetsky D E, Negoescu D M, Demarchis E H, et al. Screening and rapid molecular diagnosis of tuberculosis in prisons in Russia and Eastern Europe: a cost-effectiveness analysis. PLoS Med 2012; 9: e1001348.
41. Dye C, Lönnroth K, Jaramillo E, Williams B G, Raviglione M. Trends in tuberculosis incidence and their determinants in 134 countries. Bull World Health Organ 2009; 87: 683-691.
42. Lönnroth K, Jaramillo E, Williams B G, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009; 68: 2240-2246.
43. Belo M T C T, Luiz R R, Teixeira E G, Hanson C, Trajman A. Tuberculosis treatment outcomes and socio-economic status: a prospective study in Duque de Caxias, Brazil. Int J Tuberc Lung Dis 2011; 15: 978-981.
44. MacNeil J R, Lobato M N, Moore M. An unanswered health disparity: tuberculosis among correctional inmates, 1993 through 2003. Am J Public Health 2005; 95: 1800-1805. (Pubitemid 41369052)
45. Valin N, Hejblum G, Borget I, et al. Management and treatment outcomes of tuberculous patients, eastern Paris, France, 2004. Int J Tuberc Lung Dis 2009; 13: 881-887.
46. Dowdy D W, Cattamanchi A, Steingart K R, Pai M. Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis. PLoS Med 2011; 8: e1001063.
47. Mant D, Fowler G. Mass screening: theory and ethics. BMJ 1990; 300: 916-918. (Pubitemid 20145793)
48. Todrys K W, Amon J J. Criminal justice reform as HIV and TB prevention in African prisons. PLoS Med 2012; 9: e1001215.
49. Klitzman S, Kellner P. Control of tuberculosis in the workplace: toward an integration of occupational health and public health. Occup Med 1994; 9: 723-734.
50. Alvarez G G, Gushulak B, Abu Rumman K, et al. A comparative examination of tuberculosis immigration medical screening programs from selected countries with high immigration and low tuberculosis incidence rates. BMC Infect Dis 2011; 11: 3.
51. Hermans S M, Castelnuovo B, Katabira C, et al. Integration of HIV and TB services results in improved TB treatment outcomes and earlier prioritized ART initiation in a large urban HIV clinic in Uganda. J Acquir Immune Defic Syndr 2012; 60: e29-35.
52. Martinson N A, Hoffmann C J, Chaisson R E. Epidemiology of tuberculosis and HIV: recent advances in understanding and responses. Proc Am Thorac Soc 2011; 8: 288-293.
53. World Health Organization. WHO Three I's meeting: intensified case finding (ICF), isoniazid preventive therapy (IPT), and TB infection control (IC) for people living with HIV. Geneva, Switzerland: WHO, 2008.
54. Kranzer K, Houben R M G J, Glynn J R, Bekker L G, Wood R, Lawn S D. Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis. Lancet Infect Dis 2010; 10: 93-102.
55. Fox G J, Barry S E, Britton W J, Marks G B. Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J 2013; 41: 140-156.
56. Baussano I, Williams B G, Nunn P, Beggiato M, Fedeli U, Scano F. Tuberculosis incidence in prisons: a systematic review. PLoS Med 2010; 7: e1000381.
57. Coninx R, Maher D, Reyes H, Grzemska M. Tuberculosis in prisons in countries with high prevalence. BMJ 2000; 320: 440-442. (Pubitemid 30175778)
58. Joshi R, Reingold A L, Menzies D, Pai M. Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Med 2006; 3: e494.
59. Glynn J R, Murray J, Bester A, Nelson G, Shearer S, Sonnenberg P. Effects of duration of HIV infection and secondary tuberculosis transmission on tuberculosis incidence in the South African gold mines. AIDS 2008; 22: 1859-1867.
60. Mendes J M, Machado S M, Lourenco M C, Ferreira R M, Fonseca L de S, Saad M H. Molecular diversity of Mycobacterium tuberculosis strains in a slum area of Rio de Janeiro, Brazil. J Bras Pneumol 2008; 34: 1063-1068.
61. Maciel E L N, Pan W, Dietze R, et al. Spatial patterns of pulmonary tuberculosis incidence and their relationship to socioeconomic status in Vitoria, Brazil. Int J Tuberc Lung Dis 2010; 14: 1395-1402.
62. Dodd P J, White R G, Corbett E L. Periodic active case finding for TB: when to look? PLoS ONE 2011; 6: e29130.
63. Thind D, Charalambous S, Tongman A, Churchyard G, Grant A D. An evaluation of 'Ribolola': a household tuberculosis contact tracing programme in North West Province, South Africa. Int J Tuberc Lung Dis 2012; 16: 1643-1648.
64. Triasih R, Rutherford M, Lestari T, Utarini A, Robertson C F, Graham S M. Contact investigation of children exposed to tuberculosis in South East Asia: a systematic review. J Trop Med 2012; 2012: 301808.
65. Escombe A R, Huaroto L, Ticona E, et al. Tuberculosis transmission risk and infection control in a hospital emergency department in Lima, Peru. Int J Tuberc Lung Dis 2010; 14: 1120-1126.
66. Zuber P L, McKenna M T, Binkin N J, Onorato I M, Castro K G. Long-term risk of tuberculosis among foreign-born persons in the United States. JAMA 1997; 278: 304-307. (Pubitemid 27339658)
67. Drummond M F, Sculpher M J, Torrance G W, O'Brien B J, Stoddart G L. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford, UK: Oxford University Press, 2005.
68. Andrews J R, Lawn S D, Rusu C, et al. The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis. AIDS 2012; 26: 987-995.
69. Baltussen R, Floyd K, Dye C. Cost-effectiveness analysis of strategies for tuberculosis control in developing countries. BMJ 2005; 331: 1364.
70. Mueller D H, Mwenge L, Muyoyeta M, et al. Costs and costeffectiveness of tuberculosis cultures using solid and liquid media in a developing country. Int J Tuberc Lung Dis 2008; 12: 1196-1202.
71. Fitzpatrick C, Floyd K. A systematic review of the cost and cost-effectiveness of treatment for multidrug-resistant tuberculosis. Pharmacoeconomics 2012; 30: 63-80.
72. Trunz B B, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 2006; 367: 1173-1180.
73. Dye C, Bassili A, Bierrenbach A L, et al. Measuring tuberculosis burden, trends, and the impact of control programmes. Lancet Infect Dis 2008; 8: 233-243.
74. Korenromp E L, Bierrenbach A L, Williams B G, Dye C. The measurement and estimation of tuberculosis mortality. Int J Tuberc Lung Dis 2009; 13: 283-303.
75. Corbett E L, Marston B, Churchyard G J, De Cock K M. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 2006; 367: 926-937.
76. Mahapatra P, Shibuya K, Lopez A D, et al. Civil registration systems and vital statistics: successes and missed opportunities. Lancet 2007; 370: 1653-1663. (Pubitemid 350052272)
77. Dye C. Tuberculosis 2000-2010: control, but not elimination. Int J Tuberc Lung Dis 2000; 4(Suppl 2): S146-S152. (Pubitemid 32046274)
78. Hayes R J, Moulton L H. Cluster randomized trials. Boca Raton, FL, USA: CRC Press, 2009.
79. Okada K, Onozaki I, Yamada N, et al. Epidemiological impact of mass tuberculosis screening: a 2-year follow-up after a national prevalence survey. Int J Tuberc Lung Dis 2012; 16: 1619-1624.
80. Rendleman N J. Mandated tuberculosis screening in a community of homeless people. Am J Prev Med 1999; 17: 108-113. (Pubitemid 29354149)
81. Cavalcante S C, Durovni B, Barnes G L, et al. Community-randomized trial of enhanced DOTS for tuberculosis control in Rio de Janeiro, Brazil. Int J Tuberc Lung Dis 2010; 14: 203-209.
82. Ayles H, ZAMSTAR study team. A household-based HIV and TB intervention increases HIV testing and reduces prevalence of TB at the community level: the ZAMSTAR community randomized trial. 19th Conference on Retroviruses and Opportunistic Infections, Seattle, WA, USA, 5-8 March 2012. [Abstract 149aLB]
83. Suarez P G, Watt C J, Alarcon E, et al. The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru. J Infect Dis 2001; 184: 473-478. (Pubitemid 32718511)